Franza M, Albanesi J, Mancini B, Pennisi R, et al. The clinically relevant CHK1 inhibitor MK-8776 induces the degradation of the oncogenic protein PML-RARalpha and overcomes ATRA resistance in acute promyelocytic leukemia cells. Biochem Pharmacol 2023 Jul 3:115675. doi: 10.1016/j.bcp.2023.115675.
PMID: 37406967